Japanese Encephalitis - Pipeline Review, Q2 2011 by GlobalMarketsDirect

VIEWS: 2 PAGES: 32

Japanese Encephalitis - Pipeline Review, Q2 2011

Summary

Global Markets Direct’s, 'Japanese Encephalitis - Pipeline Review, Q2 2011', provides an overview of the Japanese Encephalitis therapeutic pipeline. This report provides information on the therapeutic development for Japanese Encephalitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Japanese Encephalitis. 'Japanese Encephalitis - Pipeline Review, Q2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Japanese Encephalitis.
- A review of the Japanese Encephalitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Japanese Encephalitis pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Japanese Encephalitis.
- Identify emerging players wi

More Info
									Japanese Encephalitis – Pipeline Review, Q2 2011




        Japanese Encephalitis - Pipeline Review, Q2 2011
                                                                                          Reference Code: GMDHC627IDB

                                                                                          Publication Date: June 2011




Japanese Encephalitis – Pipeline Review, Q2 2011                                                                        GMDHC627IDB / Pub June 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied
                                                                                                                                            Page(1)
Japanese Encephalitis – Pipeline Review, Q2 2011



Ta b le o f Co n te n ts
Table of Contents                                                                                                    2
List of Tables                                                                                                       3
List of Figures                                                                                                      4
Introduction                                                                                                         5
     Global Markets Direct Report Coverage                                                                           5
Japanese Encephalitis Overview                                                                                       6
Therapeutics Development                                                                                             7
     An Overview of Pipeline Products for Japanese Encephalitis                                                      7
Japanese Encephalitis Therapeutics under Development by Companies                                                    9
Japanese Encephalitis Therapeutics under Investigation by Universities/Institutes                                   10
Late Stage Products                                                                                                 11
     Comparative Analysis                                                                                           11
Mid Clinical Stage Products                                                                                         12
     Comparative Analysis                                                                                           12
Early Clinical Stage Products                                                                                       13
     Comparative Analysis                                                                                           13
Japanese Encephalitis Therapeutics - Products under Development by Companies                                        14
Japanese Encephalitis Therapeutics - Products under Investigation by Universities/Institutes                        15
Companies Involved in Japanese Encephalitis Therapeutics Development                                                16
     Sanofi-Aventis                                                                                                 16
     Sinovac Biotech Ltd.                                                                                           17
Japanese Encephalitis - Therapeutics Assessment                                                                     18
     Assessment by Monotherapy Products                                                                             18
     Assessment by Combination Products                                                                             19
     Assessment by Route of Administration                                                                          20
     Assessment by Molecule Type                                                                                    22
Drug Profiles                                                                                                       24
     Japanese Encephalitis Inactivated Vaccine - Drug Profile                                                       24
          Product Description                                                                                       24
          Mechanism of Action                                                                                       24
          R&D Progress                                                                                              24
     20% Diethyltoluamide - Drug Profile                                                                            25
          Product Description                                                                                       25
          Mechanism of Action                                                                                       25
          R&D Progress                                                                                              25
     Imojev - Drug Profile                                                                                          26
          Product Description                                                                                       26
          Mechanism of Action                                                                                       26
          R&D Progress                                                                                              26
     Japanese Encephalitis Chimeric Virus Vaccine + MMR II Vaccine - Drug Profile                                   28
          Product Description                                                                                       28
          Mechanism of Action                                                                                       28
          R&D Progress                                                                                              28
     ChimeriVax-JE + Stamaril - Drug Profile                                                                        30
          Product Description                                                                                       30
          Mechanism of Action                                                                                       30
          R&D Progress                                                                                              30


Japanese Encephalitis – Pipeline Review, Q2 2011                                               GMDHC627IDB / Pub June 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                             Page(2)
Japanese Encephalitis – Pipeline Review, Q2 2011


Appendix                                                                                                       31
     Methodology                                                                                               31
          Coverage                                                                                             31
          Secondary Research                                                                                   31
          Primary Research                                                                                     31
          Expert Panel Validation                                                                              32
     Contact Us                                                                                                32
     Disclaimer                                                                                                32




Lis t o f Ta b le s
Number of Products Under Development for Japanese Encephalitis, Q2 2011                                         7

Products under Development for Japanese Encephalitis – Comparative Analysis, Q2 2011                            8

Number of Products under Development by Companies, Q2 2011      
								
To top